AI assistant
Sending…
MUSTANG BIO, INC. — Director's Dealing 2017
Jun 30, 2017
35167_dirs_2017-06-30_fdfa2dd9-289e-4bc2-afce-afbb2f7a0187.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: MUSTANG BIO, INC. (NONE)
CIK: 0001680048
Period of Report: 2016-09-26
Reporting Person: WEISS MICHAEL S (Exec. Chairman of the Board)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock (Restricted) | 60000 | Indirect |
Footnotes
F1: The shares are held by Caribe BioAdvisors, LLC, of which Mr. Weiss is the sole member.
More from MUSTANG BIO, INC.
Interim / Quarterly Report
2026
May 5
Delisting Announcement
2026
Apr 17
Major Shareholding Notification
2026
Jan 5
Director's Dealing
2026
Jan 5
Director's Dealing
2025
Dec 30
Director's Dealing
2025
Dec 30
Director's Dealing
2025
Dec 30
Declaration of Voting Results & Voting Rights Announcements
2025
Dec 23
Proxy Solicitation & Information Statement
2025
Dec 3
Interim / Quarterly Report
2025
Nov 7